VEGFA and lung carcinoma: Corrective therapy to improve vascularization in the tumor by inhibiting vascular endothelial growth factor A (VEGF-A) signaling has been clinically beneficial in glioblastoma, lung cancer and age-related macular degeneration (Arjaans et al., 2016).